Infectious Complications in Relapsed Refractory Multiple Myeloma Patients After BCMA CAR T-Cell Therapy
Last Updated: Tuesday, October 19, 2021
A study assessing infectious complications in relapsed/refractory multiple myeloma patients observed 40% bacterial, 53% viral, and 6% fungal infections in 29 out of 55 multiple myeloma patients. The majority of infections post BCMA CAR T-cell therapy were mild to moderate and involved the upper or lower respiratory system.
Advertisement
News & Literature Highlights
